Skip to main navigation
Compass Therapeutics
  • Home
  • About
  • Platform
  • Pipeline
  • Clinical Trials
  • Join Us
  • Investors
  • Contact

SEC Filing Details

Investor Menu
  • Home
  • News & Events
    • News Releases
    • Events
    • Presentations
    • In the News
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & FIlings
    • SEC Filings
    • Annual Meeting
    • Annual Reports
    • Quarterly Results

SEC Filing Details

Document Details

Form
8-K
Filing Date
Feb 10, 2023
Document Date
Feb 08, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Compass Therapeutics, Inc.
Issuer
COMPASS THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

IR Contact

Mario Corso, Executive Director and Head of Investor Relations

Mario.corso@compasstherapeutics.com

Media Contact

Anna Gifford, Communications Manager

Anna.Gifford@compasstherapeutics.com

Email Alerts

  • © 2023 Compass Therapeutics, Inc.
  • Terms & Conditions
  • Privacy Policy
  • Home
  • About
  • Platform
  • Pipeline
  • Clinical Trials
  • Join Us
  • Investors
  • Contact